Video

Expert Addresses Fear and Uncertainty Patients with Cancer Feel from COVID-19 Disruptions

Author(s):

“There's a lot of miscommunication and number one, I would tell them you don't need to face these decisions alone,” Dr. Pat Basu said in an interview addressing patient’s fear in the midst of the COVID-19 pandemic.

Along with the disruption of treatment for patients with cancer as a result of COVID-19 comes fear and uncertainty over the next steps and what the landscape of cancer care will look like moving forward, but it’s important to remind patients they aren’t alone, according to Dr. Pat Basu.

In an interview with CURE®’s sister publication, CancerNetwork™, Basu, president and CEO of Cancer Treatment Centers of America, discussed how he would address the fear and uncertainty patients are facing and reminds them that they aren’t alone.

Transcription:

First of all, I would say that my heart goes out to all (patients with cancer). I've spoken to dozens, if not hundreds of patients, over the last several months, and yet, there's a lot of uncertainty out there.

There's a lot of miscommunication and number one, I would tell them you don't need to face these decisions alone. Call your provider, call me you know, I I love doing what I do and so much about cancer care is treating the body but it's also virtually holding somebody's hand. In a virtual environment we're not doing that but it's just being an empathetic listener to say let's think about this.

Number two, everything in life, and particularly in medicine, has a cost benefit ratio. And there is a very scientific very medical way of approaching the situation, here are the risks on the left hand of not, you know, not treating or diagnosing your disease and here are the risks on the right hand of, you know the COVID-19 pandemic.

And if the risks of not trading cancer outweigh the likelihood of what might happen with COVID then that means we need to treat the cancer now. It doesn't mean you just frivolously ignore COVID, it means that you maintain proper protections that we you know, we ensure that you are masked that you are socially distance that you are screen that you are tested. That you were in entering an environment where you are confident that everybody has had that done, where you're not mixing with other COVID-19 patients.

So, there are ways now where it is much better off than it would have been in the earliest weeks of March, where you know, we feel extremely confident that you can get lifesaving cancer care even while we see spikes around the country with COVID-19.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Related Content